Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.480
+0.090 (3.77%)
At close: Aug 19, 2026, 4:00 PM EDT
2.494
+0.014 (0.56%)
After-hours: Aug 19, 2026, 4:04 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $447.52 million as of August 19, 2026. Its market cap has decreased by -9.12% in one year.
Market Cap
447.52M
Enterprise Value
277.27M
1-Year Change
-9.12%
Ranking
Category
Stock Price
$2.48
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $447.52M, an increase of 2.80%. That is a compound annual growth rate of 0.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 447.52M | -53.15% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 447.15M |
| Benitec Biopharma | 442.48M |
| Editas Medicine | 442.31M |
| Ginkgo Bioworks Holdings | 439.73M |
| Inhibikase Therapeutics | 436.98M |
| Larimar Therapeutics | 423.79M |
| Atea Pharmaceuticals | 423.48M |
| X4 Pharmaceuticals | 417.41M |